Literature DB >> 7835232

Stable expression of a human liver UDP-glucuronosyltransferase (UGT2B15) with activity toward steroid and xenobiotic substrates.

M D Green1, E M Oturu, T R Tephly.   

Abstract

A full-length cDNA clone (HE8a) for a human hepatic UDP-glucuronosyltransferase was isolated from a human liver cDNA library and stably expressed in human embryonic kidney 293 (HK293) cells. Sequence analysis of the cDNA revealed that it was identical to UDPGTh-3 isolated by Chen et al. (Biochemistry 32, 10648-10657, 1993). HE8a is a member of the UGT2B gene family, and it has been designated UGT2B15. Over 100 compounds were tested for their reactivity with the expressed protein. UGT2B15 stably expressed in HK293 cells displayed glucuronidation activity toward several classes of xenobiotic substrates, including simple phenolic compounds, 7-hydroxylated coumarins, flavonoids, anthraquinones, and certain drugs and their hydroxylated metabolites. In addition, the expressed enzyme also catalyzed the glucuronidation of endogenous estrogens and androgens. Apparent KM and enzyme efficiency values for certain food-derived substrates (e.g., naringenin and eugenol) for expressed UGT2B15 were similar to those determined for endobiotic substrates, suggesting that some naturally occurring substances are good substrates for this enzyme and that glucuronidation of endogenous compounds could be affected by xenobiotics derived from dietary sources.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7835232

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  19 in total

Review 1.  Glucuronidation in humans. Pharmacogenetic and developmental aspects.

Authors:  S N de Wildt; G L Kearns; J S Leeder; J N van den Anker
Journal:  Clin Pharmacokinet       Date:  1999-06       Impact factor: 6.447

2.  Cloning and characterization of a novel human olfactory UDP-glucuronosyltransferase.

Authors:  G Jedlitschky; A J Cassidy; M Sales; N Pratt; B Burchell
Journal:  Biochem J       Date:  1999-06-15       Impact factor: 3.857

3.  Induction of UDP-glucuronosyltransferase UGT1A1 by the flavonoid chrysin in Caco-2 cells--potential role in carcinogen bioinactivation.

Authors:  A Galijatovic; Y Otake; U K Walle; T Walle
Journal:  Pharm Res       Date:  2001-03       Impact factor: 4.200

4.  Cloning and characterization of a simian UDP-glucuronosyltransferase enzyme UGT2B20, a novel C19 steroid-conjugating protein.

Authors:  O Barbier; A Bélanger; D W Hum
Journal:  Biochem J       Date:  1999-02-01       Impact factor: 3.857

5.  Genetic predisposition to the metabolism of irinotecan (CPT-11). Role of uridine diphosphate glucuronosyltransferase isoform 1A1 in the glucuronidation of its active metabolite (SN-38) in human liver microsomes.

Authors:  L Iyer; C D King; P F Whitington; M D Green; S K Roy; T R Tephly; B L Coffman; M J Ratain
Journal:  J Clin Invest       Date:  1998-02-15       Impact factor: 14.808

Review 6.  Drug interactions with grapefruit juice. Extent, probable mechanism and clinical relevance.

Authors:  U Fuhr
Journal:  Drug Saf       Date:  1998-04       Impact factor: 5.606

7.  UGT1A6 and UGT2B15 polymorphisms and acetaminophen conjugation in response to a randomized, controlled diet of select fruits and vegetables.

Authors:  Sandi L Navarro; Yu Chen; Lin Li; Shuying S Li; Jyh-Lurn Chang; Yvonne Schwarz; Irena B King; John D Potter; Jeannette Bigler; Johanna W Lampe
Journal:  Drug Metab Dispos       Date:  2011-06-10       Impact factor: 3.922

8.  Artemisinin and CYP2A6 activity in healthy subjects.

Authors:  Sara Asimus; Trinh Ngoc Hai; Nguyen Van Huong; Michael Ashton
Journal:  Eur J Clin Pharmacol       Date:  2007-12-07       Impact factor: 2.953

9.  Induction of UDP-glucuronosyltransferase by the flavonoids chrysin and quercetin in Caco-2 cells.

Authors:  A Galijatovic; U K Walle; T Walle
Journal:  Pharm Res       Date:  2000-01       Impact factor: 4.200

10.  UDP-glucuronosyltransferase 1a enzymes are present and active in the mouse blastocyst.

Authors:  Abby C Collier; Yasuhiro Yamauchi; Brittany L M Sato; Luc R A Rougée; Monika A Ward
Journal:  Drug Metab Dispos       Date:  2014-09-08       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.